E-Gift Cards Provider GiftChill Adds Vouchers of the E-Commerce Giant

This listing gives customers more cryptocurrency buying power, giving access to millions of online products. Customers will be able to transfer their Bitcoin, Ethereum, Litecoin, Bitcoin Cash, USDC and Dogecoin into gift cards that are redeemable through Amazon. This step is beneficial to two main parties: GiftChill, and cryptocurrency holders.

giftchill adds amazon gift cards

WASHINGTON, Nov. 17, 2021 (GLOBE NEWSWIRE) — GiftChill allows cryptocurrency holders to purchase gift cards from different retailers. This can be an important transaction for businesses that do not yet accept cryptocurrencies. This platform gives purchasing power that cryptocurrency does not currently have, the purchasing power they deserve. By listing Amazon E-Gift Cards, GiftChill is able to create a monumental gain for crypto holders. Amazon does not yet accept cryptocurrency as a valid form of payment, leaving investors out of the largest e-commerce platform in the world. This step will build the bridge between two of the largest communities yet.

If a crypto enthusiast is holding currency in Bitcoin, Bitcoin Cash, Ethereum, Litecoin, USDC or Dogecoin, they will be able to convert their currency into a digital gift card without placing any personal information on the GiftChill website. All gift cards have verified legitimacy and are sent via email, so the customer does not have to wait for a hard copy in the mail. Any additional information that may be needed, such as a pin or expiration date, will be included in the email, so customers do not have to worry about that information being lost or unincluded. With this voucher listing on GiftChill, a historical event is underway that includes the first-ever availability of cryptocurrency purchases on Amazon’s website. Customers will now have access to everything from groceries, electronics, and music to clothing, household items, and furniture. The future starts now, where cryptocurrency enthusiasts are able to purchase anything with their investments through GiftChill, which is trusted globally.

GiftChill can be reached on Support@giftchill.co.uk

Related Images

Image 1: giftchill adds amazon gift cards

shopping by crypto

This content was issued through the press release distribution service at Newswire.com.

Attachment

Chinese Communist Party resolution affirms ‘cult of personality’ around Xi Jinping

A historical resolution passed by the ruling Chinese Communist Party (CCP)’s Central Committee seeks to position current leader Xi Jinping as the political heir of late supreme leaders Mao Zedong and Deng Xiaoping who will take the country to new heights, surpassing the achievements of his predecessors, analysts told RFA.

The resolution — which sets out the CCP’s approved view of its own history — does so in order to mark “a new journey” for China under Xi’s “core leadership,” the preamble to the resolution, the full text of which was published on Nov. 1, says.

Its purpose is to help people think “in big-picture terms,” follow Xi as core leader, and unite the Chinese people to realize the Chinese Dream, it says.

U.S.-based political commentator Hu Ping said the omission of former leaders including Hua Guofeng, Zhao Ziyang, and Hu Yaobang from the document suggest that Xi is only interested in associating himself with hugely powerful leaders from the party’s past.

“Xi Jinping wants to position himself as not just surpassing Deng, but Mao as well,” Hu said. “The whole issue of Mao Zedong is linked to the cult of personality around him.”

“The resolution had to mention him because he’s the most important one, because when they talk about Mao, they are also talking about the present,” he said.

While the language used by the 2021 resolution on the Cultural Revolution (1966-1976) is somewhat similar to that of the 1981 resolution under Deng, most of the “disastrous results” of that era of factional fighting and social turmoil are blamed on Lin Biao and Jiang Qing, who “took advantage of Comrade Mao Zedong’s mistakes.”

It omits criticism of the cult of personality around Mao that featured in the 1981 resolution, which said Mao’s “personal arbitrariness gradually undermined democratic centralism in Party life and the personality cult grew graver and graver.”

Dismissing Mao’s mistakes

Liu Mengxiong, a former member of the Chinese People’s Political Consultative Conference (CPPCC), said the change is part of a subtle re-characterization of Mao’s legacy in official historical documents, including textbooks, over recent years.

“In the past few years, we have seen that textbooks have changed “a decade of civil strife” to “arduous exploration,” in other words, they are playing down Mao Zedong’s mistakes,” Liu told RFA. “They even … opened up the tomb of Jiang Qing [in Beijing] this year.”

He said the fact that the third resolution mostly agrees with the second on the catastrophic nature of the Cultural Revolution was rather a way to distract people from an increasingly sympathetic view of the cult of personality around Mao under Xi’s leadership.

“Xi Jinping’s core position in the CCP Central Committee is now established,” he said. “The ideas of contemporary Chinese Marxism and 21st century Marxism proves that nobody is now in a position to challenge him.”

“The [1981] resolution mentions collective leadership, but that is no longer a thing,” Liu said. “I am certain that this has laid the foundation … for Xi’s re-election [to a third term in office] at the 20th Party Congress next year.”

Establishing Xi’s authority

U.S.-based commentator Wang Juntao said Xi has succeeded in destroying the system for leadership succession set up under Deng.

“He made this resolution to establish his dictatorship,” Wang said. “Actually, now that he has the base from which to do this, he doesn’t really need [the resolution].”

“[They are talking about] establishing the absolute authority of Xi Jinping, and his political ideology, which is absurd, because that was exactly the sort of thing they repudiated in the 1981 resolution that concluded that Mao Zedong made mistakes,” he said.

Meanwhile, the resolution presents the CCP’s moves to take political control of Hong Kong under a draconian national security law as a successful response to the 2019 protest movement.

“The central authorities have firmly supported the law-based efforts of the Hong Kong Special Administrative Region to end violence and chaos and restore order … taken resolute steps to stop and prevent interference in the affairs of the two special administrative regions by external forces, and cracked down on acts of separatism, subversion, infiltration, and sabotage,” the 2021 resolution says.

“These measures, which address both the symptoms and root causes of relevant issues, have helped to restore order in Hong Kong and ensure a turn for the better in the region,” the resolution claims.

Hong Kong current affairs commentator Willy Lam said the wording on Hong Kong shows that little is likely to change if Xi stays in power at next year’s Party Congress.

“This resolution is tantamount to declaring that Xi Jinping won’t be retiring at the 20th Party Congress,” Lam said. “It also shows that although Western countries have criticized his crackdown in Hong Kong, he believes that his actions were correct.”

Translated and edited by Luisetta Mudie.

Schneider Electric recognized as a Diversity Leader by the Financial Times for third year in a row

Rueil-Malmaison (France), November 17, 2021  Schneider Electric, the global leader in the digital transformation of energy management and automation and named the World’s Most Sustainable Corporation in 2021 by Corporate Knights, has today again been recognized as a Diversity Leader in a high-profile annual survey conducted by the Financial Times and Statista.

Schneider Electric ranked 66th overall out of the 850 companies that made it onto the Financial Times Diversity Leaders 2022 ranking, and 5th in its industry. It is the third time in a row that Schneider Electric has featured high on the list – a reflection of the company’s continuous efforts to promote diversity, equity and inclusion in its 128,000-strong global workforce.

The FT’s yearly ranking aims to assess companies’ success in advancing all types of diversity in the workplace. It was developed through an independent survey of more than 100,000 employees from companies that employ at least 250 people in 16 European countries. Survey participants were asked to what extent they think their employer promotes diversity of age, gender, ethnicity, disability and sexual orientation (LGBTQ+). Participants were also given the chance to evaluate other prominent employers in their respective industries regarding diversity. The 850 highest-scoring companies were recognized as Diversity Leaders.

Schneider Electric is committed to fostering diversity, equity and inclusion among its workforce. Earlier this year, its Executive Committee, which is reponsible for the day-to-day management of the company, passed a gender-diversity milestone: 44% of its members are now female. And Schneider Electric’s wider 2025 sustainability goals include targets to boost female representation from new hires to senior leaders.

For details of other recent awards and recognitions received by Schneider Electric, including those from WeQual and Bloomberg, click here.

About Schneider Electric

Schneider’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On.

Our mission is to be your digital partner for Sustainability and Efficiency.

We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries.

We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values.

www.se.com

        Follow us on:      

Discover the newest perspectives shaping sustainability, electricity 4.0, and next generation automation on Schneider Electric Insights.

Hashtags: #LifeIsOn #SustainabilityForAll #SEGreatPeople #Meaningful #Inclusive #Empowered #OurImpact

Attachment

Informa Pharma Intelligence launches Preferred Partner Network to provide enhanced specialist support for customers’ content and technology needs

NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) — Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, announced the launch of its Preferred Partner Network to enhance the services supplied to customers across the drug development lifecycle.

Built on Informa Pharma’s deep industry expertise and years of collaborating with like-minded companies, the network will bring together hand-picked industry specialists to create a select ecosystem of best-in-class services providers. The inaugural members of the Preferred Partner Network are Blueprint Advisory, Causaly, and ROSALIND, each bringing their unique strengths in the drug development and clinical trial process.

The network will seamlessly integrate Informa Pharma’s gold-standard content with Preferred Partners’ technology and services solutions to further support decision-makers in the pharma industry. This partnership will also provide a space for growing companies to work closely with other leading content and technology providers, as well as connect with life science and healthcare communities to increase efficiency in drug development.

“By launching the Preferred Partner Network, we can take our support for customers to the next level,” said Nicky Marlin, Chief Product and Technology Officer at Informa Pharma Intelligence. “Individually, each partner provides essential technologies and services for the pharmaceutical industry, but together, we can significantly strengthen and streamline our positive contribution to the drug development landscape as a whole. We are proud to have Blueprint Advisory, Causaly, and ROSALIND™ join us as key partners in this endeavor.”

All Preferred Partners are endorsed by Informa as gold-standard vendors for integration with Informa Pharma’s content, and each partner receives individualized technical support on relevant customer projects and prioritization through Informa’s Third Party Access (TPA) Program. This includes dedicated, tailored success plans to ensure that each member achieves its goals, with the ultimate goal to deliver leading combined offerings to support mutual clients.

Blueprint Advisory

Blueprint Advisory is a Salesforce Consulting Partner with a successful track record of implementing Informa Pharma Intelligence’s APIs. Blueprint Advisory supports Informa customers’ business development and data teams throughout the discovery, implementation, and enhancement process to ensure that customers can extract value in ways that are truly impactful to their business.

Causaly

Causaly accelerates how humans acquire knowledge and develop insights in biomedicine. Causaly helps researchers and decision-makers discover evidence from millions of academic publications, clinical trials, regulatory documents, patents, and other data sources.

ROSALIND

ROSALIND™ is the first genomics discovery and collaboration platform specifically designed for scientists and biologists. ROSALIND aims to simplify the practice of genomic data interpretation, so that biologists, researchers, and drug developers can harness the potential of genomic information while reducing costs and increasing productivity.

For more information about the Preferred Partner Network, email IPIthirdpartyaccess@informa.com or visit Informa Pharma Intelligence.

About Informa Pharma Intelligence

Informa Pharma Intelligence powers a full suite of analysis products – Datamonitor Healthcare™, Sitetrove™, Trialtrove™, Pharmaprojects™, Biomedtracker™, Scrip™, Pink Sheet™ and In Vivo™ – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.

With more than 400 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information, visit pharmaintelligence.informa.com.

Informa Pharma Intelligence PR Contact
Diffusion PR for Informa Pharma Intelligence
informapharma@diffusionpr.com

HFS Ranks Virtusa Top Three Provider for Pega Services

Company recognized as a Top 3 HFS Podium Winner in 2021

SOUTHBOROUGH, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) — Virtusa Corporation has been ranked third overall in the HFS Top 10 Pega Services 2021 report. Virtusa’s ranking by industry analyst firm HFS, and recognition as a Top 3 Podium Winner, is attributed to positive customer feedback, innovative capabilities, and superior execution.

The inaugural report assesses and scores service provider participants across execution, innovation, and voice of the customer criteria. The research included a detailed RFI process conducted with 12 service providers, and reference calls and surveys of HFS’ enterprise services clients from the Global 2000.

Virtusa’s top three positioning was driven by strong rankings across key categories including:

  • Market experience and growth (ranked #2)
  • Vision and roadmap (ranked #2)
  • Breadth of services and geographic capabilities (ranked #3)
  • Overall Execution (ranked #3)
  • Overall Innovation (ranked #3)

As part of its assessment of Virtusa, HFS highlights the company’s leadership in certifications, innovation, and strong partnership with Pega in the report:

  • Virtusa received its highest average customer reference scores for the quality of the account management team, flexibility, and business understanding. One client said Virtusa is “very collaborative and a true partner.” Another commented that Virtusa is “very keen to ensure the success of the engagements.”
  • Virtusa is one of the three official modernization partners, as selected by Pega.
  • Virtusa has the highest number of Pega services clients in this research.
  • Virtusa is in the top three in this research for total Pega certifications.
  • Virtusa developed the Triple-R (Recon, Refactor, and Re-platform) set of tools and services to assist customers in modernizing, rationalizing, and optimizing their Pega applications. This spans the lifecycle of Pega services, including consulting, implementation, management, and optimization services.

“Our long-standing partnership with Pega has been built on a foundation of trust, innovation and putting the client first,” said John Gillis, Executive Vice President, Virtusa. “The combination of Virtusa and Pega – our people, expertise, solutions and collaboration – will continue to accelerate the next wave of transformation and growth for our clients. Today’s announcement and the leadership recognition from HFS is a testament to the strong partnership.”

“Virtusa stands out in the Pega ecosystem as one of the original engineering partners that has helped to build the company. This unique partnership translates into a compelling vision and roadmap for Pega services. Clients praise Virtusa’s domain knowledge as well as its flexibility to achieve the desired outcomes,” said Tom Reuner, Research Leader at HFS Research.

View the full report by visiting:  https://www.virtusa.com/lp/hfs-top-3-pegasystems-services

About Virtusa

Virtusa Corporation is a global provider of digital business strategy, digital engineering, and information technology (IT) services and solutions that help clients change, disrupt and unlock new value through innovative engineering. Virtusa serves Global 2000 companies in Banking, Financial Services, Insurance, Healthcare, Communications, Media, Entertainment, Travel, Manufacturing, and Technology industries.

Virtusa helps clients grow their business with innovative products and services that create operational efficiency using digital labor, future-proof operational and IT platforms, and rationalization and modernization of IT applications infrastructure. This is achieved through a unique approach blending deep contextual expertise, empowered agile teams, and measurably better engineering to create holistic solutions that drive the business forward at unparalleled velocity enabled by a culture of cooperative disruption.

Virtusa is a registered trademark of Virtusa Corporation. All other company and brand names may be trademarks or service marks of their respective holders.

Contact:

Matt Berry
Conversion Marketing
matt@conversionam.com

CoImmune, Inc. Announces Research Collaboration with Yeda Research and Development Company Ltd.

The agreement will support research on applications of the Synthetic Immune Niche technology, developed at the Weizmann Institute of Science and commercialized by Yeda, the commercial arm of the Weizmann Institute, in novel immunotherapies based on CoImmune’s CAR-CIK platform.

DURHAM, N.C., Nov. 17, 2021 (GLOBE NEWSWIRE) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, announced a research collaboration with Yeda Research and Development Company Ltd. (Yeda), the commercial arm of the Weizmann Institute of Science, to evaluate the applications of the Synthetic Immune Niche (SIN) technology, developed by Weizmann Institute’s researchers to enhance the expansion and function of human cytokine induced killer (CIK) cells expressing chimeric antigen receptors (CARs).

“We are very excited to join in this important collaboration with the research team at the Weizmann Institute of Science,” said Mark DeBenedette, vice president of research and development at CoImmune. “The SIN technology provides a potential methodology to enhance production of off-the-shelf allogenic cell products by providing the necessary scaffolding to support expansion and potency of CAR-CIK cells.”

The SIN technology platform, developed by the research groups of the late Professor Nir Friedman and Professor Benjamin Geiger at the Department of Immunology of the Weizmann Institute, is based on the rationale that the molecular and cellular microenvironments within the immune system can have effects on the outcome of the immune response, including stimulatory effects directed to specific immune cells. As a result, culturing immune cells on carefully selected synthetic environments may enable the conditioning of these cells for a wide range of specific adoptive immunotherapies. The chimeric antigen receptor (CAR) modified cytokine induced killer (CIK) cell platform developed by CoImmune is a variation on CAR-T therapy that is designed to enhance efficacy with greatly reduced toxicity. CIK cells are multifunctional, possessing the killing mechanisms of both T cells and NK cells, and are much more resistant to inducing GVHD compared to T cells. In addition, CoImmune’s proprietary ‘Sleeping Beauty’ gene transfer technology (SB100X) has been shown to be more efficient than recombinant viruses and less prone to off-target mutagenesis than other genetic modification technologies. In a previous clinical trial, CoImmune’s CAR-CIK product for B cell malignancies demonstrated strong clinical efficacy with little to no toxicity.

About CoImmune, Inc.
CoImmune is a privately held, clinical stage immuno-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a variation on CAR-T therapy that promises enhanced efficacy with greatly reduced toxicity. Our autologous RNA-loaded dendritic cell technology for solid tumors uses amplified total tumor mRNA to program highly engineered dendritic cells to generate immune responses against neoantigens without the need to identify them. For more information visit www.coimmune.com

About Yeda
Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda currently manages approximately 500 unique patent families and has generated the highest income per researcher compared to any other academic technology transfer operation worldwide. Through the years, Yeda has contributed to the commercialization of a number of groundbreaking therapies, such as Copaxone, Rebif, Tookad®, Erbitux®, Vectibix®, Protrazza®, Humira®, and recently the CAR-T cancer therapy Yescarta®. www.yedarnd.com

About the Weizmann Institute of Science

The Weizmann Institute of Science in Israel, is one of the world’s top-ranking multidisciplinary research institutions and offers masters’ and doctoral-level degrees across five faculties. Noted for its wide-ranging exploration of the natural and exact sciences. Institute scientists are advancing research on the human brain, artificial intelligence, computer science and encryption, astrophysics and particle physics, and they are tackling diseases such as cancer, and addressing climate change through environmental, ocean and plant sciences, and more. www.weizmann.ac.il

Investor Contact:
Lori Harrelson
Chief Financial Officer
CoImmune, Inc.
lharrelson@coimmune.com

Media Contact:
Adam Daley
Berry & Company Public Relations
adaley@berrypr.com
212.253.8881